Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

Shoulder dystocia is a rare but potentially serious obstetric emergency. Although many cases of shoulder dystocia are mild, ...

WHO has summarised its commitment to Universal Health Coverage (UHC) with the UHC cube diagram,1,2 a globally recognised ...

After decades of war, Syria transitioned to a new Government at the end of 2024, creating opportunities to rebuild the nation's infrastructure, including its mental health system.

After more than 3 years of intense negotiations, WHO member states have finally reached a consensus on a new treaty to ...

The year 2025 marks the 85th anniversary of the American Diabetes Association (ADA) Scientific Sessions, yet it arrives ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

On April 16, 2025, the UK Supreme Court ruled that only those who are what it terms as biologically female can be defined as women.1 This has wide implications for medicine as well as for people who ...

Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

The focus should be on respecting the evidence, and our lived experiences, by providing all children with an appropriate language. Proposing gene therapies for deaf children risks overlooking the ...

I will never forget that fateful moment when I was just 11 years old, walking back home from school with my friend. Unfortunately, our return coincided with a military convoy of the Syrian regime. A ...

The United States Congress has proposed cuts to Medicaid, reversing the Affordable Care Act expansion.1 These cuts could increase mortality and financial hardship for enrollees while straining ...